IP Library Granted Patent US 9,719,129
Granted Patent B2
US 9,719,129 · App. 14/122,920 · Granted Aug 1, 2017

Methods for isolating vesicles from biological fluids

Inventor: Masato Mitsuhashi (Irvine, CA)
Assignees: HITACHI CHEMICAL CO., LTD.; HITACHI CHEMICAL COMPANY AMERICA, LTD.
C12Q1/6806B01D39/2017C12N15/1003
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,719,129
App. No.
14/122,920
Granted
Aug 1, 2017
Kind
B2
Abstract

Provided is a device that collects vesicles and vesicle-like materials from biological fluids. Such devices comprise at least one sample loading region; at least one corresponding vesicle-capture material, wherein said vesicle-capture material comprises glass-like materials; and at least one corresponding sample receiving region, wherein passage of the biological fluid from the sample loading region through the vesicle capture material and into the sample receiving region results in the capture of vesicles. Additional methods provide for a method of isolating vesicles and vesicle-like materials from biological fluids are also provided.

Claims (24)

1. A method of isolating vesicles from biological fluid, comprising:

(a) obtaining a biological fluid sample comprising vesicles having a diameter of less than 0.5 micrometers;

(b) loading at least a portion of said biological fluid sample into a sample loading region of a vesicle capture device, said portion of said biological fluid sample comprising blood plasma and vesicles having a diameter of less than 0.5 micrometers;

(c) passing said portion of said biological fluid sample from said sample loading region through a vesicle-capture material in said vesicle capture device, said vesicle-capture material comprising at least a first layer and a second layer, both of glassfiber, at least a portion of said vesicles having a diameter of less than 0.5 micrometers adsorbing to and being retained by the vesicle-capture material, thereby producing a supernatant,

wherein said first layer is closer to said sample loading region than said second layer,

wherein said first layer has a porosity configured to capture material that is 1.6 micrometers or greater in diameter, wherein said second layer has a porosity configured to capture material that is 0.6 micrometers to 0.8 micrometers or greater in diameter; and

(d) passing said supernatant to a sample receiving region of said vesicle capture device, thereby isolating vesicles from the biological fluid sample.

2. The method of claim 1 , wherein said vesicle-capture material further comprises a non glass-like material.

3. The method of claim 2 , wherein said non glass-like material comprises nitrocellulose.

4. The method of claim 1 , wherein said passings are accomplished through the application of vacuum pressure to the device.

5. The method of claim 1 , wherein said passings are accomplished through the application of positive pressure to the device.

6. The method of claim 1 , wherein said passings are accomplished through low-speed centrifugation of the device.

7. The method of claim 1 , wherein said vesicle capture device is configured in a multi-well plate format.

8. The method of claim 1 , further comprising eluting said vesicles from said vesicle-capture material.

9. A method of isolating vesicle-associated RNA from a biological fluid comprising vesicles, the method comprising:

(a) obtaining a biological fluid sample comprising blood plasma and vesicles having a diameter of less than 0.5 micrometers;

(b) loading said biological fluid sample into a sample loading region of a vesicle capture device;

(c) passing said biological fluid sample from said sample loading region through a vesicle-capture material in said vesicle capture device, said vesicle-capture material comprising at least a first layer and a second layer, both of glassfiber, thereby producing a supernatant,

wherein said first layer has a porosity configured to capture particles that are 1.6 micrometers or greater in diameter, and

wherein said second layer has a porosity configured to capture particles that are 0.6 micrometers to 0.8 micrometers or greater in diameter;

(d) passing said supernatant to a sample receiving region of said vesicle capture device and discarding the supernatant,

wherein said passings result in capture of at least a portion of said vesicles having a diameter of less than 0.5 micrometers from said biological fluid sample on or in said vesicle-capture material;

(e) lysing said vesicle on or in said vesicle-capture material to create a lysate; and

(f) collecting the lysate from both of said first and second layers of said vesicle-capture material into a single receiving region, thereby isolating vesicle-associated RNA from the biological fluid sample comprising vesicles.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 22, 2024
From: RESONAC CORPORATION
To: MINARIS MEDICAL CO., LTD.
Reel/Frame 066535/0063 →
CHANGE OF NAME Recorded Jun 12, 2023
From: HITACHI CHEMICAL CO., LTD.
To: SHOWA DENKO MATERIALS CO., LTD.
Reel/Frame 063925/0670 →
CHANGE OF NAME Recorded Feb 24, 2023
From: SHOWA DENKO MATERIALS CO., LTD.
To: RESONAC CORPORATION
Reel/Frame 062796/0852 →
CHANGE OF NAME Recorded Jan 18, 2023
From: HITACHI CHEMICAL COMPANY AMERICA, LTD.
To: SHOWA DENKO MATERIALS CO., LTD.
Reel/Frame 062422/0682 →
MERGER Recorded Jun 16, 2017
From: HITACHI CHEMICAL RESEARCH CENTER, INC.
To: HITACHI CHEMICAL COMPANY AMERICA, LTD.
Reel/Frame 042739/0463 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 9, 2013
From: MITSUHASHI, MASATO
To: HITACHI CHEMICAL CO., LTD.; HITACHI CHEMICAL RESEARCH CENTER, INC.
Reel/Frame 031742/0840 →
Continuity (1)
Related Publication 20140099649A1 · Apr 10, 2014